Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola

doi:10.1186/1475-2875-7-236

Malaria Journal

Volume 7

Viewing options:

Abstract
Full text
PDF (304KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Figueiredo P
Benchimol C
Lopes D
Bernardino L
do Rosário VE
Varandas L
Nogueira F

on PubMed

Figueiredo P
Benchimol C
Lopes D
Bernardino L
do Rosário VE
Varandas L
Nogueira F
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research

Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola

Paula Figueiredo¹ , Carla Benchimol² , Dinora Lopes¹ , Luís Bernardino² , Virgílio E do Rosário¹ , Luís Varandas³ and Fátima Nogueira¹

¹UEI Malária/Centro de Malária e Doenças Tropicais/IHMT/Universidade Nova de Lisboa, Rua da Junqueira, 96, 1349-008, Lisbon, Portugal

²Hospital Pediátrico Dr. David Bernardino, Av. Amílcar Cabral, Maianga, Luanda, Angola

³UEI Clínica das Doenças Tropicais/Centro de Malária e Doenças Tropicais/IHMT/Universidade Nova de Lisboa, Rua da Junqueira, 96, 1349-008, Lisbon, Portugal

author email corresponding author email

Malaria Journal 2008, 7:236doi:10.1186/1475-2875-7-236


Published:	17 November 2008

Abstract

Background

Malaria is the infectious disease causing the highest morbidity and mortality in Angola and due to widespread chloroquine (CQ) resistance, the country has recently changed its first-line treatment recommendations for uncomplicated malaria, from CQ to artemisinin combination therapies (ACT) in adults, and sulphadoxine/pyrimethamine (S/P) in pregnant women. Loss of SP sensitivity is, however, progressing rapidly in Africa and, in this study, were investigated a number of molecular markers associated to CQ and S/P.

Methods

Blood samples were collected from 245 children with uncomplicated malaria, admitted at the Pediatric Hospital Dr. David Bernardino (HPDB), Angola, and the occurrence of mutations in Plasmodium falciparum was investigated in the pfmdr1 (N86Y) and pfcrt (K76T) genes, associated with CQ resistance, as well as in pfdhfr (C59R) and pfdhps (K540E), conferring SP resistance.

Results

The frequencies of pfmdr1 mutations in codon 86 were 28.6% N, 61.3% Y and 10.1% mixed infections (NY). The frequency of pfcrt mutations in codon 76 were 93.9% K, 5.7% T and 0.4% mixed infections (KT). For pfdhfr the results were in codon 59, 60.6% C, 20.6% R and 18.8% mixed infections (CR). Concerning pfdhps, 6.3% of the isolates were bearers of the mutation 540E and 5.4% mixed infections (K540E).

Conclusion

The results of this epidemiologic study showed high presence of CQ resistance markers while for SP a much lower prevalence was detected for the markers under study.